Nobody likes to be given a grade of F in school…or in stock ratings. Yet, these stocks have shown such poor price action recently that they have fallen to this lowly state of a POWR Rating of “F” Strong Sell.

Aphria is the most well known of the companies found on this list. This once high flying medical marijuana stock has tumbled of late. BelGene, Hecla and Mallinckrodt and Malink are other notable additions. Check out the full list of upgrades below.

Symbol/Name Price POWR Rating
AMCN
AirMedia Group Inc., each representing ten ordinary shares		 1.85 F
Strong Sell
APHA
Aphria Inc. Common Shares		 7.65 F
Strong Sell
BGNE
BeiGene, Ltd.		 119.8 F
Strong Sell
CDTX
Cidara Therapeutics, Inc.		 2.38 F
Strong Sell
EXTN
Exterran Corporation Common Stock		 17.06 F
Strong Sell
GSUM
Gridsum Holding Inc.		 2.86 F
Strong Sell
HL
Hecla Mining Company Common Stock		 2.15 F
Strong Sell
HOS
Hornbeck Offshore Services Common Stock		 1.41 F
Strong Sell
HX
Hexindai Inc. – ADR		 2.79 F
Strong Sell
KDMN
Kadmon Holdings, Inc. Common Stock		 2.3 F
Strong Sell
MGEN
Miragen Therapeutics, Inc.		 2.73 F
Strong Sell
MGNX
MacroGenics, Inc.		 16.21 F
Strong Sell
MNK
Mallinckrodt plc Ordinary Shares		 18.23 F
Strong Sell
NERV
Minerva Neurosciences, Inc		 7.03 F
Strong Sell

 

All of these stocks were recently downgraded to a POWR Rating of “F” Strong Sell. The POWR Ratings is a momentum based stock ranking system. In general, stocks don’t suffer this poor of price action unless the fundamental outlook has also become very weak.

Typically when both the fundamentals and price action head south…the stock continues to underperform into the future. The best strategy is to sell these shares and find better opportunities elsewhere. The place to look for greener pastures is our full list of ”A” rated Strong Buy stocks found here: https://stocknews.com/best-stocks/


About the Author: Steve Reitmeister


Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks. More...